Bioanalysis Zone

Strategies for effective neutralizing cell-based assays in early immunogenicity risk assessment


This white paper reviews antibody-based immune responses, and discusses the role of neutralizing antibody assays, challenges in their design, and the need for a clear immunogenicity strategy to assess and mitigate risk during drug development.

Click here for to read the full article.


Leave A Comment

Please wait...

Bioanalysis Zone New Investigator Award

Why not start this year by doing something good by nominating an early career scientist for the Bioanalysis Zone New Investigator Award. Complete the details below to register your interest!